AngioDynamics Inc

AngioDynamics Inc

ANGO · NASDAQ · Healthcare / Medical Instruments & Supplies

11.87USD-0.12 (-0.96%)

Price History

Full chart

Market Stats

Previous Close11.99
Open12.00
Day Range11.62 – 12.05
52-Week Range9.39 – 16.29
Volume280.80K
Market Cap640.24M
P/E (TTM)0.00
Forward P/E96.15
EPS-0.88
Dividend Yield0.00%
Beta0.33
50-Day Avg15.21
200-Day Avg12.41

About

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. James C. Clemmer
  • Employees632
  • Headquarters14 Plaza Drive, Latham, NY, United States, 12110, USA
  • Websitehttps://www.angiodynamics.com

Leadership

  • Mr. James C. ClemmerCEO, President & Director · b. 1964
  • Mr. Stephen A. TrowbridgeExecutive VP & CFO · b. 1974
  • Mr. Lawrence T. WeissSenior VP, Chief Legal Officer & Corporate Secretary · b. 1970
  • Mr. Warren G. NighanSenior Vice President of Regulatory Affairs, Quality & Global Supply Chain · b. 1969
  • Ms. Laura PiccininiSenior VP and GM of Cardiovascular & International · b. 1969
  • Mr. Saleem M. CheeksVice President of Communications
  • Mr. Benjamin H. DavisSenior Vice President of Business Development & Strategy · b. 1964
  • Ms. Marna I. Bronfen-MooreSenior Vice President of Human Resources · b. 1968
  • Mr. Chad T. CampbellSenior VP and GM of Oncology & Interventional Devices · b. 1971
  • Ms. Kim L. SeaburySenior Vice President of Information Technology · b. 1968

Financials

Income Statement

Currency: USD2001-05-312002-05-312003-05-312004-05-312005-05-312006-05-312007-05-312008-05-312009-05-312010-05-312011-05-312012-05-312013-05-312014-05-312015-05-312016-05-312017-05-312018-05-312019-05-312020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Total Revenue23.39M30.89M38.43M49.05M60.29M78.45M112.23M166.50M195.05M216.03M215.96M221.79M342.03M354.45M356.97M353.69M349.64M344.29M359.48M264.16M291.01M316.22M338.75M303.91M292.50M320.17M
Growth (%)-+32.06%+24.42%+27.63%+22.90%+30.12%+43.05%+48.36%+17.15%+10.76%-0.04%+2.70%+54.21%+3.63%+0.71%-0.92%-1.14%-1.53%+4.41%-26.52%+10.17%+8.66%+7.13%-10.28%-3.76%+9.46%
Cost of Revenue12.42M15.33M18.57M23.25M26.91M32.93M46.06M63.91M74.99M89.07M90.05M96.61M173.40M174.25M180.74M179.57M125.84M117.80M114.63M113.89M134.22M150.49M164.51M149.22M134.79M145.28M
Gross Profit10.97M15.56M19.86M25.80M33.38M45.52M66.17M102.59M120.06M126.97M125.70M125.31M168.51M180.17M175.80M174.32M143.95M143.86M156.00M150.27M156.79M165.73M174.25M154.70M157.71M174.89M
Gross Margin46.91%50.36%51.68%52.60%55.36%58.02%58.96%61.61%61.55%58.77%58.21%56.50%49.27%50.83%49.25%49.28%41.17%41.78%43.40%56.89%53.88%52.41%51.44%50.90%53.92%54.62%
Operating Expense11.26M13.17M16.62M20.68M25.65M35.22M77.39M86.35M103.96M106.10M113.74M129.22M162.23M169.69M179.25M173.30M155.13M158.03M165.40M317.37M192.07M194.20M225.43M347.13M197.66M214.82M
Operating Income-290.00K2.39M3.24M5.12M7.73M10.31M-11.22M16.24M16.10M20.87M11.96M-3.91M6.29M10.49M-3.45M1.02M-11.18M-14.17M-9.40M-167.10M-35.28M-28.47M-51.18M-192.44M-39.95M-39.93M
Operating Margin-1.24%7.73%8.42%10.44%12.82%13.14%-10.00%9.75%8.26%9.66%5.54%-1.76%1.84%2.96%-0.97%0.29%-3.20%-4.12%-2.61%-63.26%-12.12%-9.00%-15.11%-63.32%-13.66%-12.47%
EBITDA9.55M2.96M3.90M5.80M8.50M11.39M-7.82M25.11M27.94M32.82M23.78M10.19M34.76M37.32M24.92M28.25M13.36M8.96M16.28M-143.42M-9.28M11.13M12.19M-6.13M1.74M188.00K
EBITDA Margin40.81%9.57%10.13%11.83%14.10%14.52%-6.96%15.08%14.32%15.19%11.01%4.60%10.16%10.53%6.98%7.99%3.82%2.60%4.53%-54.29%-3.19%3.52%3.60%-2.02%0.59%0.06%
Net Income343.00K1.01M1.19M3.14M4.55M6.87M-9.13M10.89M9.93M12.31M8.12M-5.18M-1.21M2.35M-3.39M-43.59M-7.05M16.34M61.34M-166.79M-31.55M-26.55M-52.44M-184.35M-33.99M-36.74M
Net Income Margin1.47%3.27%3.09%6.41%7.54%8.75%-8.13%6.54%5.09%5.70%3.76%-2.34%-0.35%0.66%-0.95%-12.32%-2.02%4.74%17.06%-63.14%-10.84%-8.40%-15.48%-60.66%-11.62%-11.48%
R&D1.43M1.95M2.51M3.55M4.57M5.87M20.55M14.42M17.91M19.27M21.37M20.51M26.32M27.51M26.93M25.13M25.27M25.46M29.43M29.68M36.39M30.74M29.88M31.51M26.22M29.45M
R&D as % of Total Revenue6.10%6.32%6.53%7.24%7.58%7.48%18.32%8.66%9.18%8.92%9.90%9.25%7.70%7.76%7.54%7.10%7.23%7.39%8.19%11.24%12.50%9.72%8.82%10.37%8.96%9.20%
Interest Expense0000150.00K138.00K01.33M731.00K672.00K499.00K508.00K5.27M3.66M3.20M3.40M2.84M3.06M5.10M907.00K861.00K688.00K2.70M1.61M-299.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.25%0.18%0.00%0.80%0.37%0.31%0.23%0.23%1.54%1.03%0.90%0.96%0.81%0.89%1.42%0.34%0.30%0.22%0.80%0.53%-0.09%

Balance Sheet

Currency: USD2001-05-312002-05-312003-05-312004-05-312005-05-312006-05-312007-05-312008-05-312009-05-312010-05-312011-05-312012-05-312013-05-312014-05-312015-05-312016-05-312017-05-312018-05-312019-05-312020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Total Assets-20.65M27.06M49.73M59.67M137.00M383.28M408.75M408.70M423.93M437.55M725.08M791.88M800.16M773.62M728.06M707.96M705.47M836.44M595.51M561.44M552.75M532.64M317.67M280.14M267.16M
Total Liabilities-20.94M25.57M12.49M10.56M13.56M47.32M53.03M36.51M32.58M31.80M201.69M265.05M262.26M228.60M221.04M190.93M162.88M221.62M139.64M121.98M128.26M154.34M112.08M97.17M96.34M
Total Equity--295.00K1.49M37.23M49.11M123.44M335.96M355.71M372.19M391.35M405.75M523.39M526.83M537.89M545.02M507.03M517.03M542.60M614.82M455.87M439.46M424.49M378.30M205.59M182.97M170.82M
Cash-1.52M939.00K1.75M14.50M64.04M28.31M32.04M27.91M58.76M45.98M23.51M21.80M16.11M18.39M32.33M47.54M74.10M227.64M54.44M48.16M28.82M44.62M76.06M55.89M53.86M
Total Debt-16.15M19.54M6.25M3.10M2.94M17.43M17.11M7.08M6.81M6.55M150.00M151.71M153.58M147.63M133.46M105.94M93.72M136.54M40.84M22.41M33.78M64.58M4.73M10.15M-
Net Debt-14.62M18.60M4.51M-11.40M-61.11M-10.88M-14.93M-20.83M-51.95M-39.43M126.49M129.91M137.47M129.24M101.13M58.40M19.63M-91.10M-13.60M-28.16M4.96M5.20M-71.33M-45.75M-53.86M

Cash Flow

Currency: USD2002-05-312003-05-312004-05-312005-05-312006-05-312007-05-312008-05-312009-05-312010-05-312011-05-312012-05-312013-05-312014-05-312015-05-312016-05-312017-05-312018-05-312019-05-312020-05-312021-05-312022-05-312023-05-312024-05-312025-05-312026-05-31
Operating Cash Flow1.21M680.00K2.50M4.79M3.22M8.78M25.91M19.94M39.96M33.87M11.60M26.65M24.68M25.68M45.22M55.74M41.29M37.44M-14.55M24.09M-7.19M78.00K-28.16M-10.13M3.09M
Investing Cash Flow-715.00K-4.57M-996.00K-13.54M-19.10M-55.04M-26.19M-15.70M-11.78M-48.62M-175.69M-21.65M-17.05M-13.29M-7.57M-2.55M-3.66M82.55M-63.34M-13.71M-19.31M-9.75M123.72M-10.18M-5.95M
Financing Cash Flow371.00K3.31M-696.00K21.50M65.42M10.53M4.01M-8.27M2.72M1.92M142.34M-6.29M-14.02M-10.46M-23.66M-37.98M-11.55M33.93M-95.24M-16.99M7.68M25.42M-64.25M-255.00K564.00K
Capital Expenditure682.00K4.06M1.64M1.82M6.08M7.34M6.71M21.44M5.04M3.07M3.04M12.92M12.61M12.74M5.59M3.00M3.66M3.12M7.58M5.19M4.30M4.35M5.77M4.46M2.58M
Free Cash Flow524.00K-3.38M865.00K2.96M-2.86M1.45M19.20M-1.50M34.92M30.80M8.56M13.73M12.07M12.95M39.62M52.74M37.63M34.32M-22.14M18.91M-11.49M-4.27M-33.93M-14.59M508.00K
Dividends Paid----------0000000--------
FCF to OCF43.45%-497.35%34.60%61.88%-88.75%16.45%74.10%-7.51%87.38%90.94%73.78%51.52%48.92%50.41%87.63%94.62%91.14%91.67%152.12%78.47%159.73%-5479.49%120.48%144.08%16.45%
Dividend Paid to FCF----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateJul 29, 2004Oct 7, 2004Dec 20, 2004Mar 29, 2005Jul 22, 2005Sep 27, 2005Dec 20, 2005Mar 21, 2006Aug 10, 2006Sep 25, 2006Jan 3, 2007Mar 27, 2007Jul 24, 2007Oct 1, 2007Jan 3, 2008Apr 2, 2008Jul 24, 2008Oct 2, 2008Jan 6, 2009Apr 2, 2009Jul 16, 2009Oct 6, 2009Jan 5, 2010Mar 31, 2010Jul 15, 2010Oct 7, 2010Jan 4, 2011Apr 5, 2011Jul 14, 2011Oct 6, 2011Jan 5, 2012Apr 4, 2012Jul 12, 2012Oct 8, 2012Jan 3, 2013Apr 8, 2013Jul 11, 2013Oct 10, 2013Jan 9, 2014Apr 9, 2014Jul 23, 2014Oct 9, 2014Jan 8, 2015Apr 9, 2015Jul 16, 2015Oct 8, 2015Jan 7, 2016Apr 7, 2016Jul 13, 2016Oct 5, 2016Jan 6, 2017Mar 30, 2017Jul 18, 2017Sep 28, 2017Jan 4, 2018Mar 29, 2018Jul 11, 2018Sep 27, 2018Jan 4, 2019Apr 2, 2019Jul 10, 2019Oct 3, 2019Jan 7, 2020Apr 7, 2020Jul 16, 2020Sep 29, 2020Jan 7, 2021Mar 30, 2021Jul 13, 2021Sep 30, 2021Jan 6, 2022Apr 7, 2022Jul 12, 2022Oct 6, 2022Jan 5, 2023Mar 30, 2023Jul 12, 2023Oct 4, 2023Jan 5, 2024Apr 4, 2024Jul 16, 2024Oct 3, 2024Jan 8, 2025Apr 2, 2025Jul 15, 2025Oct 2, 2025Jan 6, 2026Apr 2, 2026Jul 14, 2026Oct 1, 2026
EPS Estimate0.080.040.050.080.110.090.130.140.200.120.130.160.120.100.130.120.170.090.120.130.150.080.110.120.130.080.120.130.100.090.120.080.080.090.090.050.060.050.140.170.190.110.150.160.140.110.140.140.160.130.160.150.160.160.160.190.210.180.210.220.260.040.02-0.03-0.06-0.07-0.02-0.02-0.00-0.040.01-0.010.01-0.02-0.01-0.010.02-0.13-0.07-0.15-0.17-0.15-0.11-0.13-0.12-0.12-0.10-0.11-0.11-0.10
EPS Actual0.150.060.090.100.130.100.130.140.190.140.150.140.120.100.130.120.190.090.120.150.140.090.130.130.150.080.150.150.110.080.130.090.100.100.100.080.070.120.140.160.180.160.170.120.140.110.140.150.190.170.190.190.190.120.160.250.200.160.220.190.250.080.060.01-0.060.020.010.02-0.51-0.02-0.020.030.01-0.060.01-0.030.02-0.12-0.05-0.16-0.06-0.11-0.040.03-0.03-0.10-0.150.02-0.07-
Surprise87.50%50.00%80.00%25.00%18.18%11.11%0.00%0.00%-5.00%16.67%15.38%-12.50%0.00%0.00%0.00%0.00%11.76%0.00%0.00%15.38%-6.67%12.50%18.18%8.33%15.38%0.00%25.00%15.38%10.00%-11.11%8.33%12.50%25.00%11.11%11.11%60.00%16.67%140.00%0.00%-5.88%-5.26%45.45%13.33%-25.00%0.00%0.00%0.00%7.14%18.75%30.77%18.75%26.67%18.75%-25.00%0.00%31.58%-4.76%-11.11%4.76%-13.64%-3.85%100.00%200.00%133.33%0.00%128.57%150.00%200.00%-15212.12%50.00%-300.00%400.00%0.00%-200.00%200.00%-200.00%0.00%7.69%28.57%-6.67%64.71%26.67%63.64%123.08%75.00%16.67%-52.90%118.18%36.36%-
Timing-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap640.24M
Enterprise Value601.31M
Trailing P/E0.00
Forward P/E96.15
PEG Ratio1.41
Price / Sales2.00
Price / Book3.75
EPS-0.88
Book Value4.10
Revenue (TTM)320.17M
Gross Profit (TTM)174.89M
EBITDA188.00K
Profit Margin-11.48%
Operating Margin-6.52%
Return on Equity-20.77%
Return on Assets-5.13%
Shares Outstanding41.33M
Shares Float31.79M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 3 analystsTarget 20.00
  • Strong Buy
    2
  • Buy
    1

Ownership Breakdown

Institutions
94.10%
Insiders
12.66%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    3.69M8.92%
  • Point72 Asset Management, L.P.
    3.18M7.70%
  • Systematic Financial Management LP
    2.45M5.94%
  • Armistice Capital, LLC
    1.87M4.52%
  • Broadfin Holdings LLC
    1.82M4.40%
  • Vanguard Capital Management, LLC
    1.73M4.18%
  • Royce & Associates, LP
    1.53M3.70%
  • Weber Capital Management LLC
    1.36M3.28%
  • State Street Corp
    1.33M3.23%
  • Bastion Asset Management Inc.
    1.31M3.18%
  • Nuveen, LLC
    1.22M2.94%
  • Geode Capital Management, LLC
    985.42K2.38%
  • Dimensional Fund Advisors, Inc.
    969.50K2.35%
  • Segall Bryant & Hamill
    926.71K2.24%
  • Pier Capital, LLC
    806.68K1.95%
  • Renaissance Technologies Corp
    803.28K1.94%
  • Millennium Management LLC
    783.13K1.89%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.17M2.84%
  • iShares Russell 2000 ETF
    958.54K2.32%
  • FTGF RY US SmCp Opp A USD Dis(A)
    761.32K1.84%